Stocks and Investing
Stocks and Investing
Tue, August 13, 2024
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
Matthew Caufield Reiterated (ADVM) at Strong Buy and Held Target at $30 on, Aug 13th, 2024
Matthew Caufield of HC Wainwright & Co., Reiterated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $30 on, Aug 13th, 2024.
Matthew has made no other calls on ADVM in the last 4 months.
There are 4 other peers that have a rating on ADVM. Out of the 4 peers that are also analyzing ADVM, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Matthew
- Daniil Gataulin of "Chardan Capital" Maintained at Strong Buy with Increased Target to $40 on, Thursday, July 18th, 2024
- Francois Brisebois of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Tuesday, June 25th, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $60 on, Wednesday, May 15th, 2024
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $22 on, Monday, April 29th, 2024
Contributing Sources